Article info
PDFStomach
Original article
Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival
- Correspondence to Professor Jun Yu, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Rm 707A, Li Ka Shing Medical Sciences Building, PWH, Shatin, NT, Hong Kong SAR; junyu{at}cuhk.edu.hk
Citation
Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival
Publication history
- Revised July 21, 2011
- Accepted August 8, 2011
- First published September 13, 2011.
Online issue publication
May 17, 2012
Article Versions
- Previous version (13 September 2011).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.